H.PIO Co., Ltd.

H.PIO Co., Ltd.

KKRX:357230
1,999.00
KRW
+4.00
(+0.20%)
208.99EPS
9.33P/E
83.90BMarket Cap
Nov 12Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1,827.65
4,249.77
3,950.34
4,691.43
2,824.07
5,889.43
6,254.88
6,522.23
Basic EPS, GAAP
262.32
499.44
407.95
274.76
184.5
155
204
218.14
Free Cash Flow per Basic Share
6.3
530.93
256.64
-289.8
161.45
-415.03
-14.25
61.35
Dividend per Share
9.89
14.88
8.92
74.47
23.21
48.71
35
- -
Book Value per Share
982.23
1,692.59
3,317.74
3,531.48
3,371.63
3,490.34
3,686.78
3,827.62
Tangible Book Value per Share
680.59
1,406.56
2,896.65
3,108.15
2,626.35
2,732.64
2,936.26
3,085.88
Basic Weighted Avg Shares
32
34
40
42
82
41
41
41
Sales/Revenue/Turnover
58,604
142,787
159,435
195,978
232,026
242,831
258,189
269,627
Operating Margin (%)
16.68
17.98
14.33
8.92
9.51
3.29
5.25
5.02
Depreciation Expense
460
1,209
1,799
3,038
4,567
6,180
8,171
8,735
Net Income, GAAP
8,411
16,781
16,465
11,478
15,159
6,391
8,421
9,018
Effective Tax Rate (%)
23.69
22.87
20.02
19.85
17.55
30.83
23.58
22.05
Profit Margin (%)
14.35
11.75
10.33
5.86
6.53
2.63
3.26
3.34
Working Capital
-4,346
25,640
70,866
72,657
48,963
68,769
87,794
80,132
LT Debt
148
105
1,407
1,388
2,341
12,202
11,948
7,704
Total Equity
36,766
71,174
156,323
161,648
166,328
183,470
192,196
198,664
Return on Invested Capital (%)
- -
33.62
15.35
8.55
10.72
2.94
5.03
4.99
Return on Capital (%)
- -
31.57
12.04
5.31
6.85
4.05
4.48
5.25
Return on Common Equity (%)
- -
34.56
16.38
8.19
10.98
4.57
5.69
5.95

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4,519
5,428
12,359
LT Borrowings
9,912
10,723
3,290
LT Finance Leases
2,035
2,080
4,414
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
41
41
41
Market Capitalization
99,772
96,886
83,899

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
118,810
126,610
126,825
Cash, Cash Equivalents & STI
51,301
48,547
41,575
Accounts Receivable, Net
18,844
24,083
21,039
Inventories
43,414
49,785
52,008
Total Current Liabilities
31,016
39,353
46,693
Payables & Accruals
- -
- -
- -
ST Debt
4,519
5,428
12,359
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
28.2%
4.76%
Free Cash Flow
- -
-158.79%
-96.56%
Net Income, GAAP
- -
-5.24%
31.76%
Sales/Revenue/Turnover
- -
12.79%
6.32%
Total Cash Common Dividend
- -
134.95%
-28.07%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
58,514
62,588
58,876
62,853
242,831
2025
55,493
74,874
64,341
63,481
258,189
2026
63,312
78,493
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
72
42
18
22.85
155
2025
34
60
37.36
73.41
204
2026
63.42
44
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
48.71
2025
- -
- -
- -
- -
35
2026
- -
- -
- -
- -
- -

Company Description

CEO
Taek-Geun Min
Full Time Employees
74
Sector
Health technology
Industry
Pharmaceuticals: other
Address
Seoul South Korea
IPO Date
May 14, 2021
Website
denps.com
Business
H.PIO Co., Ltd. is a South Korea-based health and lifestyle company that develops, manufactures, and distributes health functional foods, nutritional supplements, premium consumer goods, children's apparel, and derma cosmetics. Founded in 2012 and headquartered in Seoul, South Korea, the company operates across diverse consumer sectors with a core business portfolio anchored by its flagship health food brand, Denps. The company's product and service offerings comprise dietary and functional food supplements, including probiotic formulations under the Denmark Probiotics Story line; multivitamin and mineral complexes under the True Vitamin brand, including specialized focus and active formulations; inner-beauty dietary products, including Inner Seal Collagen; child nutrition and growth-oriented functional milk formulas under the High&GoGo brand; contract development, original equipment manufacturing (OEM), and original design manufacturing (ODM) for health functional foods through its manufacturing subsidiary Biopharm Co., Ltd.; premium pet food and companion animal nutrition products under the Copenhagen Recipe brand; micro-mobility equipment, including the exclusive distribution of Micro Kickboard scooters across South Korea and Japan through its subsidiary Geo Infotech Innovation Co., Ltd.; children's lifestyle apparel and accessories through its subsidiary Apricot Studios; integrated e-commerce and junior lifestyle commerce platform services operated by its subsidiary Arn Co., Ltd.; and medical-grade skincare and derma cosmetic solutions under the JOODOC brand. H.PIO conducts business operations domestically and internationally across markets including South Korea, China, Denmark, Japan, and Southeast Asia, supported by regional subsidiaries such as Denps ApS in Denmark and Denps Shanghai in China. In recent corporate developments, H.PIO has accelerated its strategic transition from a dietary supplement provider into a diversified global health, beauty, and family lifestyle enterprise. The company broadened its lifestyle and apparel operations through the acquisition of children's fashion brand Apricot Studios and the establishment of its junior lifestyle platform subsidiary Arn Co., Ltd. To advance its footprint in the personal care sector, H.PIO acquired derma cosmetics brand JOODOC and expanded into brick-and-mortar retail distribution through specialty concept stores, including Hyundai Department Store's Khōde beauty curation outlets. The company has also deepened its overseas expansion, scaling distribution of its High&GoGo and Denps product lines across Chinese and Southeast Asian e-commerce networks while reinforcing vertical supply chain integration through expanded production capabilities at Biopharm.